第　82　巻　索　引
A
acute respiratory distress syndrome,455
adult,86
adverse effect,613
AIDS,341
antibody,445
antimicrobial susceptibility,638
aseptic meningitis,177
aspergillosis,220
avidity,310
B
bacteremia,633
bacterial meningitis,187
BCG,30
blood culture,624,656
C
Campylobacter,638
cancer,419
carbapenem,6
central venous catheter,51
cervical cancer,609
child,187,419,624
Chlamydia trachomatis,182
Chlamydophila pneumoniae,451,619
Clostridium aldenense,205
Clostridium bolteae,205
Clostridium citroniae,205
Clostridium clostridioforme,205
Clostridium difficile-associated diarrhea (CDAD),419
Clostridium hathewayi,205
colonize (colonization),322
combination therapy,466
community mitigation,427
community-acquired,168
counting immunoassay (CIA),445
cross infection,213
cross-reactivity,224
cross-resistance,6
cryptosporidiosis,14
cutaneous infection,82
D
debridement,461
dental care,213
dental extraction,461
diabetes mellitus,220
diarrhea,300
dissemination,644
doubling time,292
drug resistance,6,292
E
Ec-LPS array,300
echovirus type 30,177
efficacy,414
elderly,1
enterohemorrhagic Escherichia coli (EHEC) O157:H7,304
enterovirus,55
enzyme-linked immunosorbent assay (ELISA),619
epidemiology,187,198,434
Epstein-Barr virus,451,47
Escherichia coli,300
extraction efficiency,55
G
gelatin particle agglutination antibody,310
gene diagnosis,168
gram-negative rods,285
gram stain,656
group B Streptococcus,633
H
hemagglutination inhibition antibody,310
Hemophilus influenzae,187
hepatitis B virus (HBV),213
hepatitis C virus (HCV),213
hepatitis type C,644
human papilloma virus (HPV),609
human herpesvirus 6,47
human immunodeficiency virus (HIV),20,445,650
hyponatremia,38,335
I
IgM,198,619
immune reconstitution inflammatory syndrome,341
immunochromatography,1,628
infectious mononucleosis,47,451
influenza,613
itraconazole,220
J
Japanease spotted fever,77
L
linezolid,38
lipopolysaccharide,300
longtime care facility,628
Loop-mediated isothermal amplification (LAMP),407,168
M
measles,58,198,310,328,414
meningitis,26,351,633
metallo-β-lactamase,285
metallo-β-lactamase inhibitor,285
microimmunofluorescence test (micro-IF),619
monkey pox virus,224
monoclonal antibody,224,317
MRSA,34
multidrug-resistant,322,466
multiple organ failure,77
Mycobacterium avium complex,341
Mycobacterium fortuitum,73
Mycoplasma pneumoniae,168
N
Neisseria gonorrhoeae,182,317
neonatal intensive care unit (NICU),34
neonatal,351
nested reversetranscriptase-PCR,1
neuropsychiatric events,613
neutralizing antibody,310
Nocardia beijingensis,43
nocardiosis,43
nonmotile variant,347
nontuberculous mycobacteriosis,73,644
norovirus,354,434,473,654
nosocomial infection,58,419
O
O-serogroup,300
opportunistic infection,43
Orientia tsutsugamushi,335
oseltamivir,613
osteomyelitis,30
outbreak,14,198,304,434
outer membrane protein,317
P
pandemic,427
PCR,30,285
phylogenetic analysis,177
PI3K-AKT signal transduction,161
pneumonia,168,624,628
pneumothorax,73
pre-exposure immunization,441
priority,67
Pseudomonas aeruginosa,6,285,466
pulsed-field gel electrophoresis (PFGE),304,322,351
purpura,644
pyothorax,461
Q
qualitative research,67
R
rabies,441
rapid detection,317,407
rapid diagnosis,654
real-time PCR,20,354
renal failure,650
renal salt-wasting syndrome (RSWS),38
resistant rate,638
Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP),654
Rickettsia japonica,77
risk communication,67
RNA extraction kit,55
RS virus,1
rubella,414
S
safety,414
Salmonella,347
Scedosporium apiospermum,82
scrub typhus,335
self-disclosure,213
sepsis,86,466
septic pulmonary embolism,51
septic shock,455
serotype,347,471,633
severely motorially intellectually disabled,328
sexually transmitted disease,182
shigella,322
staphylococcal scalded skin syndrome,34
Staphylococcus aureus,51,656
strand displacement amplification,182
Streptococcus bovis,26
Streptococcus pneumoniae,90,187,292,624,628
susceptibility,6,633
swimming pool,14
T
tenofovir,650
traveler’s diarrhea,471
tsutsugamushi disease,335
U
ureteral stone,455
urinary antigen,628
V
vaccination,609
vaccine,328,414,441
vertebral osteomyelitis,90
Vibrio parahaemolyticus,471
Vibrio vulnificus,407
virus-like particle,609
voriconazole,82
W
Western blot (WB),619
Y
Yersinia pseudotuberculosis 4b,86
young adult,198